Genome Editing in Cardiovascular and Metabolic Diseases

Inbunden, Engelska, 2022

2 569 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

This book provides the latest research progress on genome editing in cardiovascular and metabolic diseases and includes bioinformatics research methodology of genome editing. This book contains information about bioinformatics, genome editing in cardiovascular diseases, genome editing in metabolic diseases and therapeutic effects.

Produktinformation

Utgivningsdatum2022-12-02
Mått178 x 254 x 24 mm
Vikt939 g
FormatInbunden
SpråkEngelska
SerieAdvances in Experimental Medicine and Biology
Antal sidor339
FörlagSpringer Verlag, Singapore
ISBN9789811956416

Tillhör följande kategorier

Sjukdomar och rubbningar inom Medicin
Biovetenskap inom Naturvetenskap och teknik
Medicinsk utrustning och medicinska tekniker inom Medicin
Fysiologi inom Medicin

Dr. Junjie Xiao is the Vice Dean of the School of Life Science and also of the Medical School at Shanghai University. He is the Associate Editor of the Journal of Cardiovascular Translational Research, BMC Sports and Science, Medicine& Rehabilitation, and a member of the editorial board of BMC Medicine. He is the author or co-author of numerous scientific articles in various journals, including Cell Metabolism, Nature Communications, Annual Review of Genomics and Human Genetics, Circulation, and Theranostics. His major research interest is exercise and myocardial protection, especially using exercise as a platform to identify novel targets for enhancing cardiac regeneration and combating heart failure.

An overview of genome editing in cardiovascular and metabolic diseases.- Bioinformatics research methodology of genome editing in cardiovascular and metabolic diseases.- Online databases of genome editing in cardiovascular and metabolic diseases.- Application of systems biology for genome editing involved in regulating of cardiovascular and metabolic diseases.- Bioinformatics for reducing off-targets in cardiovascular and metabolic diseases.- Genome editing and cardiac regeneration.- Genome editing and myocardial development.- Genome editing and heart failure.- Genome editing and pathological cardiac hypertrophy.- Genome editing and cardiac remodeling.- Genome editing and diabetic cardiomyopathy.- Genome editing and cardiac arrhythmias.- Genome editing and atrial fibrillation.- Genome editing and muscle atrophy.- Genome editing and obesity.- Genome editing and fatty liver.- Genome editing and diabetes.- Genome editing and gout.- Genome editing and protein energy malnutrition.- Genome therapy and cardiovascular diseases.- Therapeutics in metabolic diseases.- Gene editing and human iPSCs in cardiovascular and editing diseases.- Prospective advances in genome editing investigation.